輸入代號或公司名稱後按 Enter
MNKD

MANNKIND CORP

+0.04 (+0.99%)前一交易日收盤 2026-09-17
美股 · Nasdaq · 製藥生技 · 製藥SIC 2834
3.59USD947K成交股數1.2B市值本益比(近四季)2.9股價營收比+42.9%營收年增(近四季)2026-11-04下次財報

財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束

逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。

營收與利潤率近 16 季

稀釋 EPS近 16 季 · 美元

現金流近 16 季

股東回饋近 16 季 · 庫藏股與股利

損益表 逐季 · 最新在左 · 小字是年增率

科目26Q226Q125Q425Q325Q225Q124Q324Q224Q123Q423Q323Q2
營收109M+43%90.2M+15%112M+60%82.1M+13%76.5M+15%78.4M+34%70.1M+37%72.4M+49%66.3M58.5M51.3M48.6M
營業成本14.4M7.5M13.9M4.5M4.6M3.8M3.2M5.6M3.8M6.1M4.0M5.2M
毛利95.0M+32%82.7M+11%98.0M+47%77.6M+16%71.9M+15%74.6M+42%66.9M+42%66.8M+54%62.4M52.4M47.3M43.4M
毛利率86.8%91.7%87.6%94.5%94.0%95.2%95.4%92.3%94.2%89.5%92.2%89.3%
研發費用18.0M17.2M27.6M14.1M13.7M11.0M12.9M11.8M10.0M9.2M10.0M6.5M
銷售管理費用58.3M54.1M58.4M29.1M31.6M25.0M23.9M24.1M22.3M61.3M10.5M11.9M
營業利益−350K-107%−1.7M-107%−7.7M-160%18.9M+14%5.3M-68%22.3M+184%12.8M+150%16.6M+865%16.7M7.9M5.1M1.7M
營業利益率-0.3%-1.8%-6.9%23.0%6.9%28.5%18.2%22.9%25.2%13.4%9.9%3.5%
稅後淨利−19.0M-2949%−16.6M-226%−15.9M-238%8.0M-496%668K-94%13.2M+839%11.6M+571%−2.0M-62%10.6M1.4M1.7M−5.3M
淨利率-17.4%-18.4%-14.2%9.7%0.9%16.8%16.5%-2.8%16.0%2.4%3.4%-10.8%
稀釋 EPS-0.06-0.05-225%-0.05-225%0.03-400%0.00-100%0.04+300%0.04+300%-0.01-50%0.040.010.01-0.02
稀釋股數309M308M314M312M311M321M285M273M325M267M324M266M

資產負債表 期末餘額

科目26Q226Q125Q425Q325Q225Q124Q324Q224Q123Q423Q323Q2
現金與約當現金52.9M52.8M74.9M127M57.0M47.3M62.4M96.6M193M238M83.0M86.2M
應收帳款43.2M28.1M38.4M17.4M27.1M28.9M18.2M23.3M19.9M14.9M21.8M27.8M
存貨44.4M49.2M35.3M27.0M28.5M28.9M26.7M24.8M26.4M28.5M27.1M25.3M
總資產732M744M792M495M412M410M464M444M481M475M320M313M
有息負債319M319M355M110M36.2M36.1M228M228M264M269M273M274M
總負債800M804M843M539M467M469M674M670M711M721M572M574M
股東權益−67.2M−59.2M−51.0M−44.6M−55.0M−58.6M−210M−226M−230M−246M−252M−260M
負債比109.2%108.0%106.4%109.0%113.4%114.3%145.2%150.9%147.8%151.8%178.6%183.1%
淨現金(現金 − 有息負債)−266M−266M−280M17.7M20.8M11.2M−166M−131M−70.9M−30.2M−190M−188M

現金流量表 單季

科目26Q226Q125Q425Q325Q225Q124Q324Q224Q123Q423Q323Q2
營業現金流−5.4M-16%−6.4M6.7M
資本支出1.9M330K2.4M
自由現金流−7.2M+8%−6.7M4.3M
折舊攤銷6.4M2.1M1.4M
買回庫藏股
現金股利
自由現金流率-8.0%-8.6%6.5%

營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度

業務分部2025 年度 · 349M
All Other Segments349M100.0%+22.2%
產品/服務2025 年度 · 457M
Product Revenue217M47.4%+21.3%
Royalty128M28.0%+25.2%
License And Service107M23.3%+5.8%
服務4.3M0.9%-6.2%
Manufacturing Services1.6M0.3%-77.5%
產品 小計114M25.0%+38.6%

各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。

年度 10-K

財年營收年增稅後淨利淨利率稀釋 EPS自由現金流
FY2025349M+22.2%5.9M1.7%0.0213.7M
FY2024286M+43.5%27.6M9.7%0.1032.8M
FY2023199M+99.4%−11.9M-6.0%-0.04−8.3M
FY202299.8M+32.2%−87.4M-87.6%-0.34−88.3M
FY202175.4M+15.8%−80.9M-107.3%-0.32−73.2M
FY202065.1M+3.3%−57.2M-87.9%-0.26−28.9M
FY201963.0M+126.3%−51.9M-82.3%-0.27−91.0M
FY201827.9M−87.0M-312.2%-0.60−38.1M